Clinical Trials Browser

vanucizumab × Clear all

NCT02665416 2020-04-07

Study Evaluating the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD), and Therapeutic Activity of Selicrelumab (RO7009789) With Vanucizumab or Bevacizumab in Participants With Metastatic Solid Tumors

Phase 1 Completed

Other solid neoplasm

Advanced/Metastatic Solid Tumors

NCT02141295 2020-03-25

McCAVE

Phase 2 Terminated

197 enrolled 24 charts

Gastrointestinal

Colorectal Neoplasms

NCT01688206 2018-10-05

A Study of Vanucizumab (RO5520985) Alone or in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

Phase 1 Completed

Neoplasms